Equillium, Inc. (EQ) intrinsic value & 10-year financials
Equillium, Inc. (EQ) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.19
- Market cap
- $68.2M
- Revenue (FY2025)
- —
- Revenue growth (9-yr CAGR)
- 61.5%
- ROIC (10-yr avg)
- 3750.3%
- Free cash flow (FY2025)
- -$22.8M
EQ 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$22.4M | -$0.39 | -$22.8M | — | 29359.0% |
| FY2024 | $41.1M | -$8.1M | -$0.23 | -$19.1M | -20.1% | -1829.4% |
| FY2023 | $36.1M | -$13.3M | -$0.38 | -$21.8M | -40.2% | 164.6% |
| FY2022 | $15.8M | -$62.4M | -$1.85 | -$9.0M | -393.9% | -1221.5% |
| FY2021 | — | -$39.1M | -$1.36 | -$32.1M | — | -90.7% |
| FY2020 | — | -$29.8M | — | -$24.8M | — | -62.8% |
| FY2019 | — | -$25.6M | — | -$23.0M | — | -66.8% |
| FY2018 | — | -$13.3M | — | -$7.6M | — | — |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Equillium, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Equillium, Inc. has historically struggled to out-earn its cost of capital, averaging just 6.4% ROIC.
Equillium, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Equillium, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-12.95 per share.